Global Sleep and Respiratory Care Devices Market Size By Type (Therapeutic Device, Monitoring Device), By Application (Household, Hospital), By Region, And Segment Forecasts, 2023 to 2032

lobal Sleep and Respiratory Care Devices Market Report Description

The Global Sleep and Respiratory Care Devices Market was valued at USD 12.3 billion in 2023 and is projected to reach USD 21.7 billion by 2031, expanding at a CAGR of 7.1% during the forecast period from 2023 to 2031. This growth is driven by the increasing prevalence of sleep disorders such as sleep apnea, rising geriatric population, and growing awareness regarding respiratory health. Technological advancements in CPAP, BiPAP, and oxygen therapy devices have significantly improved patient compliance, boosting demand. Moreover, the COVID-19 pandemic heightened awareness of respiratory care, accelerating adoption of home-use devices and telemonitoring solutions.

Drivers:

Rising Prevalence of Sleep-Related Disorders:

The global surge in conditions such as obstructive sleep apnea (OSA), insomnia, and other chronic respiratory disorders is a major market driver. OSA affects an estimated 936 million people globally, fueling demand for diagnostic and therapeutic devices.

Growth in Geriatric Population:

Aging populations are more susceptible to respiratory ailments and sleep disturbances, driving the demand for advanced respiratory care technologies, especially in developed economies.

Technological Advancements:

The integration of artificial intelligence (AI) and internet of things (IoT) in sleep monitoring and respiratory care devices has enhanced diagnostic accuracy and therapy compliance, leading to wider adoption.

Restraints:

High Cost of Advanced Devices:

While innovative devices improve treatment outcomes, their high costs, especially for home-use or portable systems, can deter adoption in price-sensitive regions.

Limited Awareness and Diagnosis Rates:

Despite the high prevalence of sleep apnea and related conditions, underdiagnosis remains a major hurdle. In many regions, awareness among patients and primary care providers is still lacking.

Opportunity:

Expansion in Emerging Markets:

Rapid urbanization, growing healthcare expenditure, and improved healthcare access in emerging economies such as India, China, and Brazil present substantial opportunities for market growth.

Telemedicine and Home Healthcare Boom:

Post-pandemic trends show a significant uptick in remote monitoring and home healthcare solutions, opening new avenues for sleep and respiratory care device manufacturers.

Market by System Type Insights:

The Therapeutic Devices segment, including CPAP, BiPAP, and oxygen therapy systems, dominated the market in 2023. These devices are widely adopted for treating sleep apnea and COPD. The monitoring devices segment is also gaining traction due to increasing consumer preference for wearable sleep trackers and connected devices for real-time data analysis and management.

Market by End-use Insights:

In 2023, the home care settings segment held the largest share, driven by the convenience and cost-effectiveness of at-home sleep and respiratory therapy. This trend is reinforced by healthcare policies encouraging out-of-hospital care. Sleep laboratories and hospitals continue to be key users, especially for initial diagnosis and acute care.

Market by Regional Insights:

North America led the global sleep and respiratory care devices market in 2023, supported by high awareness, reimbursement structures, and early adoption of new technologies. Asia-Pacific is anticipated to exhibit the fastest growth during the forecast period, due to increasing healthcare investments and rising prevalence of sleep disorders in densely populated countries.

Competitive Scenario:

Key players in the global sleep and respiratory care devices market include:

ResMed Inc.

Koninklijke Philips N.V.

Fisher & Paykel Healthcare

Invacare Corporation

Vyaire Medical

Drive DeVilbiss Healthcare

Löwenstein Medical

Apex Medical

Somnetics International, Inc.

Nidek Medical Products

These companies are focusing on strategic mergers, regional expansions, and product innovation. For instance:

In 2024, ResMed launched an AI-powered CPAP device for enhanced remote patient monitoring.

Philips introduced a wearable sleep tracker integrated with its HealthSuite platform.

Fisher & Paykel expanded its footprint in Asia-Pacific through strategic partnerships in 2023.

Scope of Work – Global Sleep and Respiratory Care Devices Market

Report Metric Details

Market Size (2023) USD 12.3 billion

Projected Market Size (2031) USD 21.7 billion

CAGR (2023–2031) 7.1%

Market Segments By System Type (Therapeutic, Diagnostic, Monitoring), By End-use (Home Care, Hospitals, Sleep Labs), By Region

Growth Drivers Rising prevalence of sleep apnea, aging population, technology integration

Opportunities Emerging markets, telemonitoring, wearable integration

Key Market Developments:

April 2024: ResMed announced the acquisition of a digital health startup to expand its AI-driven sleep apnea diagnostic solutions.

October 2023: Philips launched the DreamWear